Ross Ian Baker

11PUBLICATIONS
98CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRespiratory diseasesObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

|Apr 25, 2025
Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Ferdows Atiq, Robin Blok, Calvin B van Kwawegen

|Mar 18, 2025
Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.

Ciara Byrne, Soracha Ward, Jamie O'Sullivan

Pageof 2